Drugs which address the underlying tissue damage in COPD and prevent the progressive decline in lung function which is a hallmark of this disease are urgently needed.
-
COPD is a progressive disorder of the lungs characterised by airflow... -
Drugs which address the underlying tissue damage in COPD and prevent the... -
Ariflo (cilomilast) is an oral selective phosphodiesterase (PDE) IV inhibitor.
